| PRRAX | VGSLX | PRRAX / VGSLX | |
| Total Expense Ratio | 1.19 | 0.13 | 915% |
| Annual Report Gross Expense Ratio | 1.19 | 0.13 | 915% |
| Fund Existence | 21 years | 24 years | - |
| Gain YTD | 1.128 | 2.590 | 44% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.13B | 65.4B | 9% |
| Annual Yield % from dividends | 2.17 | 3.86 | 56% |
| Returns for 1 year | -0.68 | 2.17 | -31% |
| Returns for 3 years | 16.69 | 19.92 | 84% |
| Returns for 5 years | 20.23 | 26.29 | 77% |
| Returns for 10 years | 50.90 | 56.77 | 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRAOX | 19.38 | 0.08 | +0.41% |
| T. Rowe Price Asia Opportunities | |||
| SNXFX | 14.75 | 0.05 | +0.34% |
| Schwab 1000 Index® | |||
| GGQPX | 20.65 | 0.05 | +0.24% |
| Goldman Sachs Mid Cap Growth P | |||
| MSGRX | 12.78 | 0.02 | +0.16% |
| Meridian Small Cap Growth Institutional | |||
| GEMCX | 24.72 | 0.04 | +0.16% |
| Goldman Sachs Emerging Markets Eq C | |||